Skip to main navigation Skip to search Skip to main content

Low frequency maintenance ganciclovir for cytomegalovirus retinitis

Research output: Contribution to journalArticleResearchpeer-review

Abstract

45 patients on maintenance ganciclovir for treated cytomegalovirus (CMV) retinitis were reviewed retrospectively. Treatment was given at 30 mg/kg/week in 3 divided doses: Monday, Wednesday, Friday. The median time to clinical relapse was 5.4 months. This is similar to that reported with higher frequency maintenance regimens. The high degree of immunodeficiency (median CD4 count 16 cells/μl) and poor prognosis (median survival 8.2 months) associated with CMV retinitis were confirmed.

Original languageEnglish
Pages (from-to)43-46
Number of pages4
JournalScandinavian Journal of Infectious Diseases
Volume23
Issue number1
DOIs
Publication statusPublished - 1991
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Cite this